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Background/aim: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARSCoV-2), has been appeared first in China since December 2019. Transmission of SARS-CoV-2 occurs primarily with droplets
through coughing and sneezing and also occurs through inhalation of aerosolized secretions, which travel, remain suspended in
the air longer.
Materials and methods: Since early stages of the outbreak, COVID-19 cases have been described in healthcare workers (HCWs).
However, in the early stages, the disease may be asymptomatic. This may lead to incorrect diagnosis or delayed diagnosis and may
lead to the nosocomial spread of the virus. One of the most important causes of transmission among HCWs is being exposed to an
aerosolized virus in a closed environment for a long time. It is possible to prevent and control the spread of COVID-19 in hospitals with
outpatient treatment and triage.
Results: Infection control measures, including wearing surgical masks, hand hygiene, and social distance are considered essential
in preventing human-to-human transmissions of SARS-CoV-2. Immediate response and practices of infection control measures are
critical for saving lives during an epidemic inside and outside the hospital.
Conclusion: Analyzing current knowledge about the features of SARS-CoV-2 infection, screening, personal protection protocols, triage
and psychological support practices for healthcare professionals can be promising in terms of controlling the infection.
Key words: COVID-19, healthcare workers, infection, prevention and control

1.Introduction
Coronavirus disease 2019 (COVID-19), caused by the
severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), has been appeared first in China since December
2019 and then spread all over the world. World Health
Organization (WHO) named the disease. “COVID-19”
and declared it as a public health emergency in March
2020 [1,2]. As of June 2021, the global spread of the
virus continues worldwide, with more than 173.331.478
confirmed cases and 3.735.571 deaths. SARS-CoV 2 is
spread by inhalation of droplets 1. In addition, contact
with virus-infected sources through eyes, nose, or mouth
can also cause COVID-19 transmission. Airborne
transmission is also possible after exposure to high
concentrations of the aerosolized virus in a closed setting
for a long time. After exposure, SARS-CoV-2 virus settles
in the nose and throat, then can reproduce effectively.
Hospitals are essential areas to provide medical care for
1

patients and laboratory diagnoses. In hospitals, confirmed
and suspected cases may be isolated to prevent viral
transmission [3,4]. The transmission between patients and
healthcare workers can occur in hospital settings during
the SARS-CoV 2 outbreak. Some studies have reported
that many the nosocomial outbreaks of COVID-19 are
seen worldwide and led to difficulties in health systems.
The nosocomial outbreak may cause significant morbidity
and mortality among healthcare workers and patients.
In the early stages of the disease, there may be few mild
symptoms or may be asymptomatic. This may lead to
incorrect diagnosis or delayed diagnosis and may lead to
nosocomial spread of the disease. Studies have stated that
detecting COVID-19 cases and preventing the spread may
be difficult during the incubation period. Some patients
without typical symptoms and fever may initially be
admitted to different departments. This can create a risk
to healthcare professionals [5,6]. The aerosolized virus in

World Health Organization. WHO Coronavirus (COVID-19) Dashboard https://covid19.who.int (Accessed on June 8, 2021)
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closed areas for a long time is one of the most important
causes of transmission among HCWs. It is possible to
control and prevent the spread of COVID-19 in healthcare
facilities with outpatient treatment and triage. Initially,
suspected cases can be identified and isolated by fever
measurement, anamnesis, and evaluation of symptoms.
Highly effective case isolation and contact tracing may
control the outbreak of COVID-19 [7,8].
The COVID-19 infection prevention and control (IPC)
guidelines have been advanced based on the experience of
precautions and made interventions during MERS-CoV
or SARS-CoV outbreaks. In addition, available literature
has shown that SARS-CoV-2 is genetically similar to
other SARS viruses. However, there are some differences
from SARS-CoV other characteristics and terms of
infectiousness. We reviewed information about the virus
transmission, clinical presentations, and the transmissions
while reviewing the guidelines. We collected different
information about recommended control and prevention
of COVID-19 2,3 [9].
2. Transmission of SARS-CoV-2
Transmission of SARS-CoV-2 occurs primarily with
droplets through coughing, sneezing, and talking and
also through inhalation of aerosolized secretions, which
travel, remain suspended in the air. The droplets may
spread to about 4 m, so it may be the risk factor of
infection to HCWs [10]. Aerosol-forming processes (such
as intubation, sputum induction, and bronchoscopy) may
increase the risk of transmission of the virus. Indirect
transmission occurs when a susceptible person touches a
contaminated surface and then touches his/her nose, eyes,
and mouth. However, it is not thought to be a significant
route of transmission [11,12]. Van Doremalen et al.
showed that SARS-CoV-2 can survive on surfaces for a few
days and in aerosols for 3 h [13]. Guo et al. also identified
the SARS-CoV-2 virus on the shoe soles of HCWs [14].
This transmission may be important to spread the virus
in healthcare settings. Patients should be screened for
symptoms of COVID-19 upon entry into a health care
setting. Suspected COVID-19 patients should be directed
into a well-ventilated private room; such patients should

not wait among other patients. Patients without symptoms
should be questioned about any unprotected exposures
to a person with COVID-19 within the last 14 days. If
patients have had contact with suspected or confirmed
COVID-19 cases, they may need to be quarantined. All
of the guidelines and the studies to date recommend early
diagnosis and isolation of patients to reduce exposures to
SARS-CoV-2 [9,15].
3.Environmental disinfection and control
All guidelines recommend that environmental infection
control procedures should be implemented to help reduce
the spread of SARS-CoV-2. The routine cleaning and
disinfection procedures of the CDC have been found
appropriate for SARS-CoV-2 infections. Patients with
suspected or confirmed COVID-19 should be placed
in negative pressure rooms or a well-ventilated singleoccupancy room with a closed door and dedicated
bathroom; when this is not possible, patients with
confirmed SARS-CoV-2 infection can be housed together
[16].
Environmental services workers who are responsible
for cleaning the areas should be trained for appropriate
cleaning procedures. In order to reduce contamination,
surface disinfection can be achieved by using a disinfectant
such as 1/100 diluted bleach or chlorine tablet after
cleaning with water and soap. It is recommended to be
used for durable surfaces, as chlorine compounds can
cause corrosion on surfaces. For sensitive surfaces, 70%
alcohol can be used for surface disinfection by keeping
it for 1 min. On the contaminated surfaces, disinfection
is done with 1/10 diluted bleach or chlorine tablet and
waiting until it dries 4 [17].
Hand hygiene and physical separation and are
important in reducing the spreading of the virus in hospital
settings. All guidelines recommend control measures such
as barriers measures to manage patients, physical barriers
in the reception area for triage, airflow management and
closed systems for intubated patients. Air conditioners
and fans should not be used in common areas, central
ventilation systems should be used 5,6 [16,17].

Centers for Disease Control and Prevention. Interim Infection Prevention and Control Recommendations for Healthcare PersonnelDuring the
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4. Occupational risk for health care workers
In the database of WHO surveillance, HCWs
definition includes physicians, nurses, health workers
(physiotherapists, laboratory staff, patient transporters,
etc.), and support staff, (laundry and cleaning personnel,
reception clerks, etc.). HCWs are at high risk for
COVID-19, and since early in the outbreak, COVID-19
cases in HCWs were reported. Before COVID-19 vaccines,
according to the WHO data, 14% of COVID-19 cases were
among HCWs 7. Chou et al. reported that SARS-CoV-2
infection incidence in HCWs is between 0.4%–49.6%, and
the prevalence of SARS-CoV-2 seropositivity ranged from
1.6%–31.6% [18]. In other reports, HCWs have accounted
for 3.8%–19% of COVID-19 cases. Li et al. reported that
there was no case among HCWs until January 1, 2020,
and there was a 10% increase in 20 days after [19]. In a
metaanalysis including the USA, China and European
countries, it was reported that approximately 57.1% of
healthcare workers were infected with COVID-19. In fact,
2736 healthcare worker deaths were documented with a
death rate of 0–0.90/100.000 in the reporting countries
until August 15, 2020 [20,21].
SARS-CoV-2 can spread from small liquid particles in
the nose or mouth, ranging from droplets when the person
coughs, sneezes, or talks. Also, the virus can be spreadable
after inhalation or inoculation. In particular, inadequate
use of PPE in infected patient rooms and exposure to
infected workers in break rooms and common areas have
been identified as major risk factors to HCWs [22].
The infection control precautions when caring for a
patient with confirmed or suspected COVID-19 in the
health care setting:
· When entering a patient’s room, a gown and gloves
and PPE that provides respiratory, eye, and face protection
should be worn by HCWs.
· N95 and higher-level respiratory protection
equipment are suggested rather than a medical mask to
provide both barrier and respiratory protection.
A medical mask or a face shield can be used over the
N95/FFP2 mask to reduce external contamination. It can

be used for 8 h with transitions between patients without
removing the mask. Masks can be hidden in a clean
environment by wrapping them in a breathable paper
bag or paper towel. It is not recommended to use a nylon
bag for this purpose. It should not be used more than five
times under these storage conditions. For example, the UK
guideline recommends that PPE be used for about 2–6 h,
while the ECDC guidelines recommend for up to 4–6 h 8,9.
· For eyes or face protection, goggles or a face shield
should be used because eyeglasses are insufficient.
· If it is not possible to follow up in an isolation room,
it would be appropriate to cohort patients in a large room.
However, the distance between patients and healthcare
professionals may differ according to the guidelines. The
protective distance recommendations are 1 m for WHO,
1.5 m for Australia, and 2 m for CDC10.
A systematic review suggests that the occupational risk
may be increased in specific clinical settings by inadequate
hand hygiene. A risk assessment for SARS-CoV-2 should be
performed to determine the level of risk for SARS-CoV-2
occupational exposure, implement adequate measures to
reduce it, and protect healthcare workers. The workplace
risk levels may be helpful for occupational health services
for potential occupational exposure to SARS-CoV-2.
These classification of risk factors are shown in Table 11.
The precautions according to their level of risk have
been recommended to prevent exposure of healthcare
workers to SARS-CoV-2, following WHO guidelines.
Because of medical conditions, older age, or pregnancy,
some HCWs may be at risk for severe COVID-19 illness.
They should not work with the medium, high, or very highrisk levels following WHO recommendations. In general,
pregnant HCWs may continue to work in patient-facing
roles until they give birth if all recommended personal
protective equipment (PPE) is available. However, it is
reasonable to limit exposure to patients with confirmed
or suspected COVID-19, particularly during higher-risk
procedures or unvaccinated. Some newly graduated or
student HCWs may be at greater risk because they are
unknown to control procedures or prevent errors while

Washingston State Department of Health. COVID-19 Confirmed Cases by Occupation andIndustry.https://www.doh.wa.gov/Portals/1/
Documents/1600/coronavirus/covid_occupation_ industry_summary_2020-06-12.pdf (Accessed on July 14, 2020)
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system/uploads/attachment_data/file/990923/20210602_Infection_Prevention_and_Control_Guidance_for_maintaining_services) (Published on
January 10, 2020)
8

Infection prevention and control for the care of patients with 2019-nCoV in healthcare settings. ECDC technical report. https: //www.ecdc.europa.
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April 27, 2020)
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2020)
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Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed. Interim guidance, 29 June 2020.
Geneva: World Health Organization (https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC2020. (Accessed on November 20, 2020)
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Table. Risk levels, corresponding measures for prevention, and mitigation of occupational exposure to SARS-CoV-2 among health
workers.
Lower-risk

Medium-risk

High-risk

Close contact with people who
Without close contact and not Close contact with patients
are known to be or suspected
to contact with people known or visitors, not contacting
of infection with SARS-CoV-2
or suspected of infection with people known or suspected of
or contact with surfaces
SARS-CoV-2
infection with SARS-CoV-2
contaminated with the virus

practicing. In particular, appropriate task delegation and
role assignment can be considered for these healthcare
professionals. Working for a long time without breaks
and inadequate PPE leads to fatigue and inadequate
compliance with infection prevention practices. According
to WHO guidelines, adequate staffing levels and adequate
infection prevention and control training are strongly
recommended for effective IPC programs to prevent
healthcare-associated infections [9,16].
The essential point of infection control measures
to reduce transmission of SARS-CoV-2 includes early
diagnosis, source control and isolation of suspected
patients, environmental disinfection, and use of appropriate
PPE. Generally, PPE is used for short periods when the
exposure cannot be avoided or controlled otherwise. The
research suggests that prolonged use of gloves and frequent
hand hygiene may cause or aggravate hand eczema or latex
allergy to sensitive people. For latex allergy, the use of nonlatex or nitrile gloves is advised. Moisturizing creams help
to decrease irritation [9,16,18].
Increasing inappropriate use of disinfectants in
healthcare facilities can also cause toxic effects among
healthcare workers and cleaners. HCWs involved in
the application of disinfectants should be evaluated for
medical contraindications, provided with adequate PPE.
Spraying with disinfectants (such as in a tunnel, cabinet, or
chamber) is not recommended under any circumstances
[16].
In all health care facilities, the effectiveness of
ventilation systems may be consulted to experts to assess
and contain the spread of infected particles. Aerosolgenerating procedures should be performed in rooms
with appropriate air exchange capacities, and exposure
to COVID19 without adequate protection should be
investigated. HCWs should be reported if they exposure to
COVID19 without adequate protection [9,22].
Vaccination is one of the strategies to reduce the risk
of acquiring COVID-19 in health care settings, including
vaccination of HCWs. Unless there is a contraindication
such as allergic reactions, COVID-19 vaccine is indicated

3218

Very high-risk
With risk of exposure to aerosols
of SARS-CoV-2, in settings where
aerosol procedures are performed or
working in crowded places without
adequate ventilation, long working
hours, inappropriate use of PPE for
healthcare professionals

for all HCWs. The studies report that it reduces SARSCoV-2 infections in HCWs. Some systemic signs and
symptoms (fever, myalgia, headache, arthralgia, etc.) can
occur after vaccination. It can be challenging to distinguish
these manifestations from signs and symptoms of
COVID-19. For this reason, it is essential to follow up after
vaccination, and a COVID PCR test may be required for
differential diagnosis. Screening of HCWs for symptoms
and evidence of exposure for COVID 19 can be used in
addition to the overall infection control program. It is
essential to identify people with COVID-19 in healthcare
institutions to reduce the transmission of the virus. A study
reported that of 48 HCWs with confirmed COVID-19, 65%
worked for approximately two days although they have the
symptoms of COVID-19. This study determined that 17%
of symptomatic healthcare workers were overlooked by
more limited symptom screening (fever, cough, shortness
of breath, sore throat, etc.) [23,24].
Whether HCWs have been vaccinated against
COVID-19, where the exposure occurred, distance from
the source patient, exposure time (>15 min in 24-h
period), whether there is an aerosol-generating procedure,
whether he uses personal protective equipment, whether
the patient wears a mask should be questioned to assess
exposure. Exposure is considered high risk if HCW was
in the room during an aerosol-generating procedure,
was not wearing all of the recommended PPE, and had
prolonged close contact (within 2 m for ≥15 min over
24 h). All other exposures can be considered low risk. In
HCWs, indications for quarantine depend primarily upon
whether the exposure is considered high or low risk and
whether the HCW had SARS-CoV-2 infection within the
last 90 days [9,16].
5. Conclusion
It is impossible to be up-to-date for COVID-19 because
new studies and guidelines are published daily. Infection
control procedures should target all patient care
procedures that address the risks of transmission by taking
into account all possible routes of transmission. The main

KALIN ÜNÜVAR et al. / Turk J Med Sci
infection control measures, including wearing surgical
masks, hand hygiene, and social distance are considered
essential in preventing human-to-human transmissions
of SARS-CoV-2. Immediate response and practices of
infection control measures are critical for saving lives
during an epidemic inside and outside the hospital.
Analyzing current knowledge about the features of SARSCoV-2 infection, screening, personal protection protocols,

triage and psychological support practices for healthcare
professionals can be promising in terms of controlling the
infection.
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